Verge Genomics is a startup based in the United States, 1 tracked investor.
Verge Genomics is a company headquartered in the United States. Brouky records 1 investor associated with the company.
Verge Genomics uses machine learning applied to human genomics and biological data to discover and develop small-molecule therapeutics for neurodegenerative diseases such as ALS.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.